biomerica.png
Biomerica Announces inFoods® IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024
May 13, 2024 08:19 ET | Biomerica, Inc.
With IBS affecting 10 to 15% of the global population, the associated $21 billion in direct medical costs and absenteeism underscores the urgent need of innovative solutions. Recognized as the 7th...
SentiBioLogo.jpg
Senti Bio Announces First Patient Dosed in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia
May 13, 2024 08:15 ET | Senti Biosciences, Inc.
Senti Bio today announced that patient dosing has commenced in the Phase 1 clinical trial of SENTI-202.
Figure One
Benitec Biopharma Releases Third Quarter 2024 Financial Results and Provides Operational Update
May 13, 2024 08:15 ET | Benitec Biopharma Inc.
-Positive Interim Clinical Trial Data for the First Oculopharyngeal Muscular Dystrophy (OPMD) Subject Dosed with BB-301 in the Phase 1b/2a Clinical Treatment Study Reported in April- -The Second OPMD...
logo.jpg
Royalty Pharma to Present at Upcoming Investor Conferences
May 13, 2024 08:15 ET | Royalty Pharma plc
NEW YORK, May 13, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in the following upcoming investor conferences during the month of May: RBC...
logo.jpg
Cheetah Net Supply Chain Service Inc. Announces 1st Quarter 2024 Results and Provides Corporate Update
May 13, 2024 08:05 ET | Cheetah Net Supply Chain Services Inc
CHARLOTTE, N.C., May 13, 2024 (GLOBE NEWSWIRE) -- Cheetah Net Supply Chain Service Inc. (“Cheetah” or the “Company”) (Nasdaq CM: CTNT), a supplier of parallel-import vehicles sourced in the U.S. to...
terns-color.png
Terns Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Updates
May 13, 2024 08:05 ET | Terns Pharmaceuticals, Inc.
Interim data from initial dose escalation cohorts from Phase 1 CARDINAL trial of TERN-701 (allosteric BCR-ABL) in CML expected in 2H24 Top-line data from Phase 1 trial of TERN-601 (oral GLP-1) for...
csw logo.jpg
CSW Industrials Announces Date for Fiscal Fourth Quarter and Full Year 2024 Earnings Release Conference Call
May 13, 2024 08:02 ET | CSW Industrials, Inc.
DALLAS, May 13, 2024 (GLOBE NEWSWIRE) -- CSW Industrials, Inc. (NASDAQ: CSWI) announced that it will release its earnings results for the fiscal fourth quarter and year ended March 31, 2024 on...
Ferroglobe.jpg
Ferroglobe PLC Schedules First Quarter 2024 Earnings Call for May 15, 2024
May 13, 2024 08:00 ET | Ferroglobe PLC
Ferroglobe PLC Schedules First Quarter 2024 Earnings Call for May 15, 2024
Jasper.png
Jasper Therapeutics Announces Briquilimab Development Program in Asthma
May 13, 2024 08:00 ET | Jasper Therapeutics, Inc.
Expanding Portfolio of Mast Cell Programs with Plans to Initiate a Phase 1b/2a study in Patients with Asthma in Q4 2024Company to Host Key Opinion Leader Webinar on the Potential of Briquilimab in...
Collegium_rgb_large_R.jpg
Collegium Announces $35 Million Accelerated Share Repurchase Program
May 13, 2024 08:00 ET | Collegium Pharmaceutical, Inc.
STOUGHTON, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people...